Academic Journal
Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy
| العنوان: | Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy |
|---|---|
| المؤلفون: | Wong, Carlos K. H., Chen, Julie, Fung, Samuel K. S., Mok, Maggie, Cheng, Yuk lun, Kong, Irene, Lo, Wai Kei, Lui, Sing Leung, Chan, T. M., Lam, Cindy L. K. |
| المساهمون: | Health and Medical Research Fund |
| المصدر: | BMC Nephrology ; volume 21, issue 1 ; ISSN 1471-2369 |
| بيانات النشر: | Springer Science and Business Media LLC |
| سنة النشر: | 2020 |
| الوصف: | Background This study aimed to determine the lifetime cost-effectiveness of first-line dialysis modalities for end-stage renal disease (ESRD) patients under the “Peritoneal Dialysis First” policy. Methods Lifetime cost-effectiveness analyses from both healthcare provider and societal perspectives were performed using Markov modelling by simulating at age 60. Empirical data on costs and health utility scores collected from our studies were combined with published data on health state transitions and survival data to estimate the lifetime cost, quality-adjusted life-years (QALYs) and cost-effectiveness of three competing dialysis modalities: peritoneal dialysis (PD), hospital-based haemodialysis (HD) and nocturnal home HD. Results For cost-effectiveness analysis over a lifetime horizon from the perspective of healthcare provider, hospital-based HD group (lifetime cost USD$142,389; 6.58 QALYs) was dominated by the PD group (USD$76,915; 7.13 QALYs). Home-based HD had the highest effectiveness (8.37 QALYs) but with higher cost (USD$97,917) than the PD group. The incremental cost-effectiveness ratio (ICER) was USD$16,934 per QALY gained for home-based HD over PD. From the societal perspective, the results were similar and the ICER was USD$1195 per QALY gained for home-based HD over PD. Both ICERs fell within the acceptable thresholds. Changes in model parameters via sensitivity analyses had a minimal impact on ICER values. Conclusions This study assessed the cost-effectiveness of dialysis modalities and service delivery models for ESRD patients under “Peritoneal Dialysis First” policy. For both healthcare provider and societal perspectives, PD as first-line dialysis modality was cost-saving relative to hospital-based HD, supporting the existing PD First or favoured policy. When compared with PD, Nocturnal home Home-based HD was considered a cost-effective first-line dialysis modality for ESRD patients. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1186/s12882-020-1708-0 |
| DOI: | 10.1186/s12882-020-1708-0.pdf |
| DOI: | 10.1186/s12882-020-1708-0/fulltext.html |
| الاتاحة: | http://dx.doi.org/10.1186/s12882-020-1708-0 http://link.springer.com/content/pdf/10.1186/s12882-020-1708-0.pdf http://link.springer.com/article/10.1186/s12882-020-1708-0/fulltext.html |
| Rights: | http://creativecommons.org/licenses/by/4.0/ ; http://creativecommons.org/licenses/by/4.0/ |
| رقم الانضمام: | edsbas.422C5232 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1186/s12882-020-1708-0 |
|---|